glp 1 alzheimer's Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders π§Will GLP-1RA drugs be the
Description
Track your appetite levels, weight, body measurements, and energy levels throughout the trial period
Obesity as pleiotropic risk state for metabolic and mental health throughout life
What is certain is that more research is necessary to answer the question
"The companies and the FDA, no one's identified an endgame with these drugs," Kessler says
Duca, F
